PHILADELPHIA, June 21 /PRNewswire/ -- United Research Laboratories/Mutual
 Pharmaceutical Company today announced that the U.S. Food and Drug
 Administration (FDA) has approved Mutual Pharmaceutical's Abbreviated New Drug
 Application (ANDA) for Tramadol HCl 50mg Tablets.  Mutual Pharmaceutical's
 Tramadol HCl 50mg Tablets are indicated for the management of moderate to
 moderately severe pain in adults.
     Mutual's Tramadol HCl 50mg Tablets are the generic equivalent of and are
 AB-rated to Ultram, manufactured and marketed by Ortho-McNeil Pharmaceutical,
 a Johnson & Johnson Company.  Ortho-McNeil's Ultram enjoyed sales of over
 $650,000,000 in 2001.
     Mutual's Tramadol HCl 50mg Tablets are available for immediate shipment
 under both the United Research Laboratories label and the Mutual
 Pharmaceutical Company label, and offered in 100, 500, and 1000 count bottles.
     United Research Laboratories/Mutual Pharmaceutical Company, headquartered
 in Philadelphia, was founded in 1946 as one of the first generic
 pharmaceutical distributors and manufacturers in the United States. URL/Mutual
 continues to be a pioneer in the industry, specializing in applying
 in-licensed patented drug-delivery and stabilization technologies to
 successfully formulate and commercialize difficult to formulate products. The
 Company has received 8 ANDA approvals from the FDA over the last 8 months and
 is on target to file a further 10 ANDA submissions by YE2002. Also, the
 Company is currently in discussions with eight of the world's fifteen largest
 branded pharmaceutical companies regarding the application of proprietary
 technologies to existing and future branded products for commercialization.
     For further information, please call 1-800-523-3684, ext. 1320 for Dr. Lai
 Ogunbiyi, Vice-President, Business Development or ext. 1045 for William
 Sirico, Director of Marketing.
 
                     MAKE YOUR OPINION COUNT -  Click Here
                http://tbutton.prnewswire.com/prn/11690X91435134
 
 

SOURCE  United Research Laboratories/Mutual Pharmaceutical Company